Disclosed is an encapsulated composition comprising at least one core-shell microcapsule. The at least one core-shell microcapsule comprises a core comprising at least one benefit agent and a shell surrounding the core. The shell comprises a first and a second polyelectrolyte which form a complex coacervate. The microcapsule comprises at least one interfacial enabler.

The invention relates to the use of an ampholyte copolymer as a colloidal stabilizer in the preparation of aminoplast core-shell microcapsules containing an active material, wherein the ampholyte copolymer comprises: 2 to 99 mol % of cationic monomer having at least one quaternary ammonium group, 1 to 98 mol % of acrylic based monomer, 0 to 97 mol % of non-ionic monomer,
and wherein the ampholyte copolymer has more cationic charges than anionic charges, wherein the cationic charges of the ampholyte copolymer are exclusively due to the at least one quaternary ammonium group of the cationic monomer.

The invention relates to the use of an ampholyte copolymer as a colloidal stabilizer in the preparation of aminoplast core-shell microcapsules containing an active material, wherein the ampholyte copolymer comprises: 2 to 99 mol % of cationic monomer having at least one quaternary ammonium group, 1 to 98 mol % of acrylic based monomer, 0 to 97 mol % of non-ionic monomer,
and wherein the ampholyte copolymer has more cationic charges than anionic charges, wherein the cationic charges of the ampholyte copolymer are exclusively due to the at least one quaternary ammonium group of the cationic monomer.

The invention relates, in part, to a method of producing silica vesicles including under controlled conditions to thereby heavily influence the morphology and characteristics of the vesicles. The vesicles are shown to be effective as delivery agents for chemical and biological agents. They are also shown to be useful in methods of treatment and as components of an immunogenic composition.

The invention relates, in part, to a method of producing silica vesicles including under controlled conditions to thereby heavily influence the morphology and characteristics of the vesicles. The vesicles are shown to be effective as delivery agents for chemical and biological agents. They are also shown to be useful in methods of treatment and as components of an immunogenic composition.

This device comprises a hollow body, the hollow body defining: an internal conduit for distributing the first fluid, the internal conduit defining an inner volume; an external conduit or distributing the second fluid, the internal conduit and the external conduit extending coaxially along a longitudinal axis (AA). It at least comprises one metal tube extending along the longitudinal axis (AA) and being positioned in the inner volume of the internal conduit and/or in the downstream extension of the internal conduit and/or of the external conduit.

This device comprises a hollow body, the hollow body defining: an internal conduit for distributing the first fluid, the internal conduit defining an inner volume; an external conduit or distributing the second fluid, the internal conduit and the external conduit extending coaxially along a longitudinal axis (AA). It at least comprises one metal tube extending along the longitudinal axis (AA) and being positioned in the inner volume of the internal conduit and/or in the downstream extension of the internal conduit and/or of the external conduit.

An encapsulated perfume composition comprising at least one perfume-containing aminoplast core-shell microcapsule dispersed in an aqueous suspending medium, the microcapsule being characterized in that it bears a positive charge.

An encapsulated perfume composition comprising at least one perfume-containing aminoplast core-shell microcapsule dispersed in an aqueous suspending medium, the microcapsule being characterized in that it bears a positive charge.

This method comprises the following steps: flowing drops of a first phase, through a circulation duct, into a second phase that is substantially immiscible with the first phase, each drop comprising a core formed from the first phase and a shell formed from a layer of coacervate inserted between the first phase and the second phase; recovering a dispersion containing drops and the second phase in a container; injecting a solution for increasing the viscosity of the second phase in the circulation duct or at the outlet of the circulation duct, upstream from the container.